Metronidazole vs. H. pylori: How It Works—and Fails
Metronidazole remains a first-line therapy for Helicobacter pylori in Latin America, despite widespread resistance. Because the drug requires intracellular activation to damage bacterial DNA, even small disruptions in bacterial metabolism can render it ineffective, driving treatment failure, persistent infection, and preventable disease.
Metronidazole Is Failing H. pylori Treatment in Latin America
Metronidazole is rapidly failing as a first-line Helicobacter pylori treatment in Latin America. High resistance rates in Colombia, Peru, and Brazil exceed safe empiric thresholds, driving treatment failure, persistent infection, and increased gastric cancer risk.
Multidrug-Resistant H. pylori in Gastric Cancer Patients from Colombia
Genetic mutations drive widespread multidrug resistance in Helicobacter pylori strains from Colombia, limiting the effectiveness of standard treatments and underscoring the need for precision-based therapy.
Puerto Ricans and Mexicans Face Greater Risk of Liver Disease from H. pylori
New research shows that H. pylori, a common stomach infection, may raise the risk of fatty liver disease in Hispanics, especially Puerto Rican and Mexican adults. With nearly half of participants affected, the study highlights the need for early screening and awareness in Latino communities already burdened by obesity and diabetes.
The Silent Threat of H. pylori in Hispanic Health
Helicobacter pylori (H. pylori) is more than just a stomach infection, it’s a hidden threat with serious consequences for Hispanic health. Beyond ulcers and gastritis, research shows links to gastric cancer, liver disease, and even metabolic disorders. Because Hispanic populations face higher infection rates, awareness, early detection, and treatment are critical in reducing long-term risks and improving overall health.
High Antibiotic Resistance Threatens H. pylori Treatment in Latin America
Rising antibiotic resistance is undermining H. pylori treatment in Latin America, with high resistance to metronidazole (53%) and clarithromycin (12%). Experts urge regional surveillance and recommend switching to regimens with lower resistance, like amoxicillin or tetracycline.
Is H. pylori Contagious? What You Need to Know
Affecting millions worldwide and hitting Hispanic and Latino communities hardest, this silent infection spreads easily in close living conditions. Knowing how H. pylori spreads is crucial to preventing infection and protecting your family.
Hidden Risk: H. pylori Infection and Gastritis Prevalent in Symptom-Free Hispanics
Figure 1. Hispanic heritage photo. Source: itoldya420.getarchive.net Helicobacter pylori (H. pylori) is a bacterium that can survive in the stomach’s acidic environment. Although many people with H. pylori show no symptoms, it is a known cause of chronic gastritis. More…
Helicobacter pylori Disproportionately Affects Latinos in the U.S. and Latin America
Helicobacter pylori infection disproportionately affects Latinos in the U.S. and Latin America, increasing the risk of gastritis and stomach cancer.
What’s your Latino background? You could be infected with Helicobacter Pylori
Here, I talk about a recent scientific paper showing that there is a difference in H. pylori seroprevalence, or frequency of infection, based on Hispanic/Latino cultural background and multiple factors associate with the disease.
What Hispanics think of using AI in healthcare and medicine
AI is creeping into our lives, including medical research and provider care. But, what do Hispanics think of using AI in health and medicine?
AI can discriminate against minorities and spread scientific misinformation
Note. This is updated from a previous blog post I published a long time ago in robotic healthcare on November 29,2018 >>> Hello, World! You may remember from the pre-COVID times the use of the new genome editing technique CRISPR-Cas9…
Recent Comments